FibroBiologics (FBLG) Debt Ratio (2022 - 2026)

FibroBiologics (FBLG) has reported Debt Ratio for 4 consecutive years, with 0.02 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Debt Ratio fell 97.3% year-over-year to 0.02; the trailing twelve-month figure through Jun 2026 stood at 0.02 (down 97.3% YoY), and the FY2025 full-year result was 1.21, up 98.32% from the prior year.
• Debt Ratio fell to 0.02 in Q2 2026 per FBLG's latest filing, from 0.04 in the prior quarter.
• Across five years, Debt Ratio topped out at 1.21 in Q4 2025 and bottomed at 0.01 in Q3 2024.
• Historically, Debt Ratio has averaged 0.48 across 4 years, with a median of 0.51 in 2025.
• The sharpest annual moves came in 2025 and 2026: Debt Ratio jumped 9998.78% in 2025, then tumbled 97.3% in 2026.
• Over 4 years, Debt Ratio stood at 1.13 in 2022, then slumped by 46.19% to 0.61 in 2024, then surged by 98.32% to 1.21 in 2025, then plunged by 98.7% to 0.02 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.02, 0.04, and 1.21 for Q2 2026, Q1 2026, and Q4 2025 respectively.